# Albemarle Corporation (ALB) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Chemicals. Price $126.28, market value $14.9 billion.

## Valuation
- **P/E (trailing): 467.7×** (5-yr avg 76.0×, 3-yr avg 10.4×). Albemarle Corporation trades at 467.7× trailing earnings, well above its own five-year average of 76.0×: investors are paying up relative to the company's past. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 11.2×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.23**. A PEG of 0.23 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.5×**. Each dollar of revenue is priced at 2.5×.
- **Price / book: 1.9×**. The shares trade at 1.9× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 18.4×**. Enterprise value is 18.4× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 9.0%** (5-yr avg -2.1%). Free cash flow equals 9.0% of the market value, above its five-year average of -2.1%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 0.2%**. The inverse of the P/E: 0.2% of the price is earned each year.

## Profitability
- **Gross margin: 23.8%**. Albemarle Corporation keeps 23.8% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 4.3%**. 4.3% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: -9.9%**. The company reported a net loss over the last twelve months.
- **Return on equity: -5.4%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 1.8%**. Return on all capital, debt included, is 1.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 1.4%**. Each dollar of assets produces 1.4% of profit.

## Growth
- **Revenue growth (1 yr): -4.4%** (3-yr -11.1%/yr, 5-yr 10.4%/yr). Revenue fell 4.4% over the last year, against 10.4% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 48.6%**. Earnings per share rose 48.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 2.3%/yr**. Free cash flow has compounded at 2.3% a year over three years.

## Financial health
- **Debt to equity: 0.33**. Debt is 0.33 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 1.8×**. It would take 1.8 years of operating earnings to repay net borrowings, within the comfortable range.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 1.30%** ($1.62 per share, trailing). Albemarle Corporation yields 1.30%, a modest yield more typical of a growth-oriented payer.
- **Consecutive years of increases: 23**. 23 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 1.0%/yr** (1-yr 0.6%). The dividend has grown 1.0% a year over five years.

## Analyst view
- **Analyst consensus: buy** (20 analysts). 20 analysts cover Albemarle Corporation; the consensus is buy, with an average price target of $172.56 (+37% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 61.5%** (YTD -10.3%, 3-mo -18.6%). The shares are up 61.5% over twelve months including dividends.
- **From 52-week high: -42.9%** (77.2% above the low). Trading 43% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 42**. An RSI of 42 is neutral.
- **Beta (1 yr): 1.43** (volatility 59%). Beta of 1.43 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ALB · Page: https://foliofundamentals.com/stocks/alb

Not investment advice.